The use of dosimetry in the treatment of differentiated thyroid cancer.
M Lassmann, H Hänscheid, FA Verburg… - The Quarterly Journal …, 2011 - europepmc.org
The standard treatment for the ablation of thyroid remnant tissue following surgery as well as
for the treatment of iodine avid metastases in patients suffering from differentiated thyroid …
for the treatment of iodine avid metastases in patients suffering from differentiated thyroid …
Advantages of dosimetry in 131I therapy of differentiated thyroid carcinoma.
FA Verburg - The Quarterly Journal of Nuclear Medicine and …, 2019 - europepmc.org
For advanced differentiated thyroid carcinoma (DTC) several iodine-131 (131I) activity
selection strategies are available. The most common approach empirical activity selection …
selection strategies are available. The most common approach empirical activity selection …
Individualized dosimetry in the management of metastatic differentiated thyroid cancer
C Chiesa, MR Castellani, C Vellani… - … Quarterly Journal of …, 2009 - search.proquest.com
This paper analyzes the available data on the dosimetric approach and describes the use of
dosimetry in the Division of Nuclear Medicine of the National Cancer Institute in Milan …
dosimetry in the Division of Nuclear Medicine of the National Cancer Institute in Milan …
Radioiodine therapy dosimetry in benign thyroid disease and differentiated thyroid carcinoma
M Salvatori, M Luster - European journal of nuclear medicine and …, 2010 - Springer
Traditionally, nuclear medicine has been regarded mainly as a diagnostic specialty in which
the administration of radioactive substances yields information whose importance far …
the administration of radioactive substances yields information whose importance far …
Physics aspects of setting up a multicenter clinical trial involving internal dosimetry of radioiodine treatment of differentiated thyroid cancer.
J Taprogge, F Leek, GD Flux - … of the Italian Association of Nuclear …, 2019 - europepmc.org
The field of molecular radiotherapy is expanding rapidly, with the advent of many new
radiotherapeutics for the treatment of common as well as for rare cancers. Treatment …
radiotherapeutics for the treatment of common as well as for rare cancers. Treatment …
Personalized dosimetry in the context of radioiodine therapy for differentiated thyroid cancer
M Pacilio, M Conte, V Frantellizzi, MS De Feo… - Diagnostics, 2022 - mdpi.com
The most frequent thyroid cancer is Differentiated Thyroid Cancer (DTC) representing more
than 95% of cases. A suitable choice for the treatment of DTC is the systemic administration …
than 95% of cases. A suitable choice for the treatment of DTC is the systemic administration …
Dosimetry in the therapy of metastatic differentiated thyroid cancer administering high 131I activity: the experience of Busto Arsizio Hospital (Italy).
L Bianchi, A Baroli, G Lomuscio… - The Quarterly Journal …, 2012 - europepmc.org
Aim The purpose of the present work was to evaluate the impact of 131I high activity therapy
treatments of metastatic differentiated thyroid cancer (MDTC) in terms of feasibility …
treatments of metastatic differentiated thyroid cancer (MDTC) in terms of feasibility …
Clinical radionuclide therapy dosimetry: the quest for the “Holy Gray”
B Brans, L Bodei, F Giammarile, O Lindén… - European journal of …, 2007 - Springer
Introduction Radionuclide therapy has distinct similarities to, but also profound differences
from external radiotherapy. Review This review discusses techniques and results of …
from external radiotherapy. Review This review discusses techniques and results of …
Pre-therapeutic blood dosimetry in patients with differentiated thyroid carcinoma using 124-iodine: predicted blood doses correlate with changes in blood cell counts …
V Hartung-Knemeyer, J Nagarajah, W Jentzen… - Annals of nuclear …, 2012 - Springer
Objective Pre-therapeutic blood dosimetry prior to a high-dose radioiodine therapy (RAIT) is
recommended and a blood dose of 2 Gy is considered to be safe. In this study, changes in …
recommended and a blood dose of 2 Gy is considered to be safe. In this study, changes in …
Indirect assessment of the maximum empirical activity (250 mCi) with respect to dosimetry concepts in radioiodine therapy of metastatic differentiated thyroid cancer
Aim The development of reliable dosimetry models promotes the individualized therapy
concept toward more success and less complications. This paper evaluates the traditional …
concept toward more success and less complications. This paper evaluates the traditional …